Cargando…

Recombinant Full-Length Hepatitis C Virus E1E2 Dimer Elicits Pangenotypic Neutralizing Antibodies

An effective prophylactic vaccine would be beneficial for controlling and eradicating hepatitis C virus (HCV) infections. However, the high diversity across HCV genotypes is a major challenge for vaccine development. Selection of the appropriate immunogen is critical to elicit broad HCV neutralizing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Tianli, Chi, Xiaojing, Liu, Xiuying, Pan, Shengnan, Chen, Wenfang, Duan, Huarui, Zhang, Xinhui, Yang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273934/ https://www.ncbi.nlm.nih.gov/pubmed/35837406 http://dx.doi.org/10.3389/fimmu.2022.831285

Ejemplares similares

An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
por: Chi, Xiaojing, et al.
Publicado: (2022)

Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening
por: Yang, Xuehua, et al.
Publicado: (2023)

Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan
por: Chang, Kao-Chi, et al.
Publicado: (2021)

Predicting the strength of UP-elements and full-length E. coli σ(E) promoters
por: Rhodius, Virgil A., et al.
Publicado: (2012)

Recombinant Sheep Pox Virus Proteins Elicit Neutralizing Antibodies
por: Chervyakova, Olga V., et al.
Publicado: (2016)

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2021)

Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice
por: Krapchev, Vasil B., et al.
Publicado: (2018)

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization
por: Meng, Yanxiang, et al.
Publicado: (2023)

Recombinant full-length Bacillus Anthracis protective antigen and its 63 kDa form elicits protective response in formulation with addavax
por: Sharma, Shikhar, et al.
Publicado: (2023)

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
por: Maughan, A., et al.
Publicado: (2019)

Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals
por: Flisiak, Robert, et al.
Publicado: (2023)

Near full length genome of a recombinant (E/D) cosavirus strain from a rural area in the central region of Brazil
por: da Costa, Antonio Charlys, et al.
Publicado: (2018)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Co-immunization with two recombinant Eimeria tenella lines expressing immunoprotective antigens of E. maxima elicits enhanced protection against E. maxima infection
por: Tang, Xinming, et al.
Publicado: (2019)

The role of full-length apoE in clearance of Gram-negative bacteria and their endotoxins
por: Petruk, Ganna, et al.
Publicado: (2021)

Purification of full-length recombinant human huntingtin proteins with allelic series of polyglutamine lengths
por: Kim, Hyeongju, et al.
Publicado: (2021)

Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in Mice
por: Zhu, Shu, et al.
Publicado: (2015)

Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection
por: Sicras-Mainar, Antoni, et al.
Publicado: (2020)

Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis
por: Zoratti, Michael J., et al.
Publicado: (2020)

Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome
por: Tam, Albert W., et al.
Publicado: (1991)

Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020)

Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice
por: Li, Yaohui, et al.
Publicado: (2020)

Production, Purification and Characterization of Recombinant, Full-Length Human Claudin-1
por: Bonander, Nicklas, et al.
Publicado: (2013)

Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
por: Du, Lanying, et al.
Publicado: (2009)

In vivo expression and function of hybrid Ia dimers (E alpha A beta) in recombinant and transgenic mice
Publicado: (1989)

An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses
por: Ge, Ningning, et al.
Publicado: (2022)

Search for missing neutrals in e+e- collisions
por: Chiappetta, P
Publicado: (1987)

Characterization of Full-Length and Truncated Recombinant κ-Carrageenase Expressed in Pichia pastoris
por: Yu, Yuan, et al.
Publicado: (2017)

Sedimentation Velocity Analytical Ultracentrifugation of Oxidized Recombinant Full-Length Factor VIII
por: Zakas, Philip M., et al.
Publicado: (2020)

Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison
por: Chen, Chun-Ting, et al.
Publicado: (2022)

Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains
por: Zhang, Ye, et al.
Publicado: (2022)

Optimized Expression of Full-Length IgG1 Antibody in a Common E. coli Strain
por: Chan, Conrad En Zuo, et al.
Publicado: (2010)

Construction of phosphorylation interaction networks by text mining of full-length articles using the eFIP system
por: Tudor, Catalina O., et al.
Publicado: (2015)

Characterization of the Specificity, Functionality, and Durability of Host T‐Cell Responses Against the Full‐Length Hepatitis E Virus
por: Brown, Anthony, et al.
Publicado: (2016)

ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors
por: Okuno, Yosuke, et al.
Publicado: (2022)

Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice
por: Li, Yue-Xiang, et al.
Publicado: (2014)

Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
por: Abreu-Mota, Tiago, et al.
Publicado: (2018)

Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice
por: Hu, Mary C., et al.
Publicado: (2007)

Intranasal Protollin Formulated Recombinant SARS-CoV S Protein Elicits Respiratory and Serum Neutralizing Antibodies
por: Barnard, Dale, et al.
Publicado: (2007)

Structural Basis for a Neutralizing Antibody Response Elicited by a Recombinant Hantaan Virus Gn Immunogen
por: Rissanen, Ilona, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sus1ll1qebi62op8pgdqsplc1t